|Bid||0.2000 x 0|
|Ask||0.2100 x 0|
|Day's Range||0.1600 - 0.2500|
|52 Week Range||0.1600 - 0.8750|
|Beta (3Y Monthly)||-0.01|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.79|
Attractive stocks have exceptional fundamentals. In the case of Anatara Lifesciences Limited (ASX:ANR), there's is a...
Anatara Lifesciences Limited's (ASX:ANR): Anatara Lifesciences Limited engages in the development of non-antibiotic oral solutions for gastro intestinal diseases in animals and humans in Australia. The company...
Anatara Lifesciences Limited (ASX:ANR), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. However, the trade-off is ANRRead More...
Every investor in Anatara Lifesciences Limited (ASX:ANR) should be aware of the most powerful shareholder groups. Institutions often own shares in more established companies, while it's not unusual to see Read More...
Anatara Lifesciences Limited (ASX:ANR) is a company with exceptional fundamental characteristics. Upon building up an investment case for a stock, we should look at various aspects. In the case of Read More...